104
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration

, , , , , , , & show all
Pages 5591-5601 | Published online: 01 Dec 2014

References

  • AngelborgCHillerdalMHultcrantzELarsenHCThe microsphere method for studies of inner ear blood flowORL J Otorhinolaryngol Relat Spec19885063553623068609
  • JuhnSKRybakLPLabyrinthine barriers and cochlear homeostasisActa Otolaryngol1981915–65295346791457
  • InamuraNSaltANPermeability changes of the blood–labyrinth barrier measured in vivo during experimental treatmentsHear Res1992611–212181526884
  • JuhnSKHunterBAOdlandRMBlood-labyrinth barrier and fluid dynamics of the inner earInt Tinnitus J200172728314689642
  • MukherjeaDRybakLPSheehanKECurrent strategies for drug delivery to the inner earExpert Opin Drug Discov20116549150522646075
  • WagnerNCayé-ThomasenPLaurellGBagger-SjöbäckDThomsenJCochlear hair cell loss in single-dose versus continuous round window administration of gentamicinActa Otolaryngol2005125434034515823802
  • SaltANPlontkeSKPrinciples of local drug delivery to the inner earAudiol Neurootol200914635036019923805
  • LiuHFengLToliaGLiddellMRHaoJLiSKEvaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testingDrug Dev Ind Pharm201440789690323631539
  • ChenGZhangXYangFMuLDisposition of nanoparticle-based delivery system via inner ear administrationCurr Drug Metab2010111088689721208174
  • PaulsonDPAbuzeidWJiangHOeTO’MalleyBWLiDA novel controlled local drug delivery system for inner ear diseaseLaryngoscope2008118470671118182968
  • MinorLBSchesselDACareyJPMeniere’s diseaseCurr Opin Neurol200417191615090872
  • LefebvrePPStaeckerHSteroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot studyActa Otolaryngol2002122769870212484644
  • GoycooleaMVThe round window membrane under normal and pathological conditionsActa Otolaryngol Suppl199249343551636422
  • BjurstromSSlepeckyNAngelborgCA histopathological study of the inner ear after administration of hyaluronan into the middle ear of the guinea pigActa Otolaryngol Suppl198744262653481168
  • DuXChenKKuriyavarSMagnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigsOtol Neurotol2013341414723187928
  • BuckiováDRanjanSNewmanTAMinimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membraneNanomedicine (Lond)2012791339135422475648
  • PritzCODudásJRask-AndersenHSchrott-FischerAGlueckertRNanomedicine strategies for drug delivery to the earNanomedicine (Lond)2013871155117223837855
  • Di ToroRBettiVSpampinatoSBiocompatibility and integrin mediated adhesion of human osteoblasts to PLGA copolymersEur J Pharm Sci2004212–316116914757487
  • AcharyaSSahooSKPLGA nanoparticles containing various anti-cancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
  • TamuraTKitaTNakagawaTDrug delivery to the cochlea using PLGA nanoparticlesLaryngoscope2005115112000200516319613
  • GeXJacksonRLLiuJDistribution of PLGA nanoparticles in chinchilla cochleaeOtolaryngol Head Neck Surg2007137461962317903580
  • PatelNRDamannKLeonardiCSabliovCMSize dependency of PLGA-nanoparticle uptake and antifungal activity against Aspergillus flavusNanomedicine (Lond)2011681381139521651442
  • ChenYCHsiehWYLeeWFZengDTEffects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrierJ Biomater Appl201327790992222207601
  • ZhangXChenGMuLResearch progress of novel dosage forms and pharmaceutical technologies for effective components of Danshen and Sanqi and their combinationZhong Cheng Yao20113315681570
  • GuoGLiBWangYEffects of salvianolic acid B on proliferation, neurite outgrowth and differentiation of neural stem cells derived from the cerebral cortex of embryonic miceSci China Life Sci201053665366220602267
  • QiaoZMaJLiuHEvaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injuryMolecules20111612100021001222138858
  • FujitaKHakubaNHataRGinsenoside Rb1 protects against damage to the spiral ganglion cells after cochlear ischemiaNeurosci Lett2007415211311717296266
  • LinXQCurative effect survey of compound root of red rooted salvia injection liquid treating sudden deafnessAnhui Yi Yao20015175176
  • HuangZPTwo cases of Danshen tablets and other drug for treatment of Ménière’s diseaseNei Moivgol Med J20053227
  • GaoDTangSTongQOleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug deliveryInt J Nanomedicine201273517352622848175
  • FeiXChenXLiangGPreparation, characterization, and biodistribution of breviscapine proliposomes in heartJ Drug Target200917540841419555267
  • JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249011055295
  • LuWZhangYTanYZHuKLJiangXGFuSKCationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain deliveryJ Control Release2005107342844816176844
  • ChenYFJawIShiaoMSDetermination and pharmacokinetic analysis of salvianolic acid B in rat blood and bile by microdialysis and liquid chromatographyJ Chromatogr A200510881–214014516130743
  • HanMFangXLDifference in oral absorption of ginsenoside Rg1 between in vitro and in vivo modelsActa Pharmacol Sin200627449950516539852
  • LiQWangYFengNFanZSunJNanYNovel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatomaJ Drug Target2008161072573219005937
  • GoycooleaMVClinical aspects of round window membrane permeability under normal and pathological conditionsActa Otolaryngol2001121443744711508501
  • SwanEEMescherMJSewellWFTaoSLBorensteinJTInner ear drug delivery for auditory applicationsAdv Drug Deliv Rev200860151583159918848590
  • JuhnSKHamaguchiYGoycooleaMReview of round window membrane permeabilityActa Otolaryngol Suppl198945743482648755
  • HeWHornSWHussainMDImproved bioavailability of orally administered mifepristone from PLGA nanoparticlesInt J Pharm20073341–217317817101249
  • KumarAChenFMozhiAInnovative pharmaceutical development based on unique properties of nanoscale delivery formulationNanoscale20135188307832523860639